ADAPTIMMUNE THERAPEUTICS PLC Cost of Revenue
ADAPTIMMUNE THERAPEUTICS PLC (ADAPY) reported Cost of Revenue of $2.50 million for the 3-month period ending 2025-06-30, per its 10-Q filed 2025-08-13.
Financial Statements › Expense Statement
us-gaap:CostOfGoodsAndServicesSold · last filed 2025-08-13
- ADAPTIMMUNE THERAPEUTICS PLC cost of goods and services sold for the quarter ending 2025-06-30 was $2.50M.
- ADAPTIMMUNE THERAPEUTICS PLC cost of goods and services sold for the quarter ending 2025-03-31 was $879.00K.
- ADAPTIMMUNE THERAPEUTICS PLC cost of goods and services sold for fiscal 2024 was $70.00K.
| Period end | Cost of Goods and Services Sold 3 month | Cost of Goods and Services Sold 6 month | Cost of Goods and Services Sold 12 month |
|---|---|---|---|
| 2025-06-30 | $2.50M 10-Q · filed 2025-08-13 | $3.38M 10-Q · filed 2025-08-13 | |
| 2025-03-31 | $879.00K 10-Q · filed 2025-05-13 | ||
| 2024-12-31 | $70.00K 10-K · filed 2025-03-24 | ||
| 2024-06-30 | $0.00 10-Q · filed 2025-08-13 |